Inhalable responsive polysaccharide-based antibiotic delivery nanoparticles to overcome mucus barrier for lung infection treatment
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Inhalation and Respiratory Drug Delivery · Advanced Drug Delivery Systems · Cystic Fibrosis Research Advances
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia10.1016/S2213-2600(19)30140-7 ↗
2. The Lancet Respiratory Medicine, Pneumonia research: time to fill in the gaps, Lancet Respir. Med. 7, 2019, 993.10.1016/S2213-2600(19)30400-X ↗
3. Pneumonia10.1038/s41572-021-00266-1 ↗
4. The Chinese Centers for Disease Control and Prevention (CDC) Etiology of Respiratory Infection Surveillance Study Team, Etiological and epidemiological features of acute respiratory infections in China, Nat. Commun. 12, 2021, 5026.
5. The first global forum on childhood pneumonia10.1016/S2213-2600(20)30054-0 ↗
6. CPAP treatment for children with pneumonia in low-resource settings10.1016/S2213-2600(17)30347-8 ↗
7. Evaluating the impact of pulse oximetry on childhood pneumonia mortality in resource-poor settings10.1038/nature16043 ↗
8. Pharmacokinetics and pharmacodynamics of oral and intravenous omadacycline10.1093/cid/ciz309 ↗
9. Monosized polymeric microspheres designed for passive lung targeting: biodistribution and pharmacokinetics after intravenous administration10.1021/acsnano.9b09773 ↗
10. TOBI Podhaler - Novartis. www.ema.europe.com.
11. Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases? Drug Delivery and Transl
12. A biomimetic non-antibiotic approach to eradicate drug-resistant infections10.1002/adma.201806024 ↗
13. Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia10.1016/j.biomaterials.2018.01.022 ↗
14. Engineering of nebulized metal-phenolic capsules for controlled pulmonary deposition10.1002/advs.201902650 ↗
15. Nano into micro formulations of tobramycin for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis10.1021/acs.biomac.7b00945 ↗
16. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles10.1016/j.biomaterials.2008.12.076 ↗
17. Lipid shell-enveloped polymeric nanoparticles with high integrity of lipid shells improve mucus penetration and interaction with cystic fibrosis-related bacterial biofilms10.1021/acsami.7b19762 ↗
18. Mediated drug release from nanovehicles by black phosphorus quantum dots for efficient therapy of chronic obstructive pulmonary disease10.1002/anie.202008379 ↗
19. PEGylation for enhancing nanoparticle diffusion in mucus10.1016/j.addr.2017.08.010 ↗
20. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus10.1073/pnas.0608611104 ↗
21. A dual-responsive antibiotic-loaded nanoparticle specifically binds pathogens and overcomes antimicrobial-resistant infections10.1002/adma.202006772 ↗
22. Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery10.1002/adma.201202847 ↗
23. Infection microenvironment-related antibacterial nanotherapeutic strategies10.1016/j.biomaterials.2021.121249 ↗
24. Rough carbon-iron oxide nanohybrids for near-infrared-II light-responsive synergistic antibacterial therapy10.1021/acsnano.1c00894 ↗
25. A β-lactamase-imprinted responsive hydrogel for the treatment of antibiotic-resistant bacteria10.1002/anie.201600205 ↗
26. Bacteria-responsive intelligent wound dressing: simultaneous in situ detection and inhibition of bacterial infection for accelerated wound healing10.1016/j.biomaterials.2018.01.024 ↗
27. pH-responsive, light-triggered on-demand antibiotic release from functional metal–organic framework for bacterial infection combination therapy10.1002/adfm.201800011 ↗
28. pH switchable nanoplatform for in vivo persistent luminescence imaging and precise photothermal therapy of bacterial infection10.1002/adfm.201909042 ↗
29. pH-responsive polymer-drug conjugate: an effective strategy to combat the antimicrobial resistance10.1002/adfm.202002655 ↗
30. Ag nanoparticles cluster with pH-triggered reassembly in targeting antimicrobial application10.1002/adfm.202000511 ↗
31. Physical double-network hydrogel adhesives with rapid shape adaptability, fast self-healing, antioxidant and NIR/pH stimulus-responsiveness for multidrug-resistant bacterial infection and removable wound dressing10.1002/adfm.201910748 ↗
32. Targeted antibacterial therapy: Ag nanoparticles cluster with pH-triggered reassembly in targeting antimicrobial applications10.1002/adfm.202070106 ↗
33. Biofilm-sensitive photodynamic nanoparticles for enhanced penetration and antibacterial efficiency10.1002/adfm.202103591 ↗
34. Polycaprolactone/polysaccharide functional composites for low-temperature fused deposition modelling
35. PEGylated polyaspartamide-polylactide-based nanoparticles penetrating cystic fibrosis artificial mucus10.1021/acs.biomac.5b01480 ↗
36. Tuning the softness of poly(2-hydroxyethyl methacrylate) nanocomposite hydrogels through the addition of PEG coated nanoparticles10.1016/j.jcis.2020.06.043 ↗
37. Poly(lactide-co-glycolide) nanoparticles for prolonged therapeutic efficacy of esculentin-1a-derived antimicrobial peptides against pseudomonas aeruginosa lung infection: in vitro and in vivo studies, Biomacromolecules
38. Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus10.1073/pnas.1214066109 ↗
39. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo10.2217/nnm-2016-0047 ↗
40. Smart aminoglycoside hydrogel with tunable gel degradation, on-demand drug release, and high antibacterial activity10.1016/j.jconrel.2017.01.003 ↗
41. Synthesis and characterization of Schiff base contained dextran microgels in water-in-oil inverse microemulsion10.1016/j.carbpol.2016.06.091 ↗
42. Ultrasmall TPGS−PLGA hybrid nanoparticles for site-specific delivery of antibiotics into Pseudomonas aeruginosa biofilms in lungs10.1021/acsami.9b19644 ↗
43. The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles10.1016/j.addr.2017.11.002 ↗
44. Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa10.1016/j.jconrel.2014.07.061 ↗
45. Nociceptor sensory neurons suppress neutrophil and γδ T cell responses in bacterial lung infections and lethal pneumonia10.1038/nm.4501 ↗
46. Acute lower respiratory tract infection10.1056/NEJMra074111 ↗
47. Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin10.1128/AAC.48.9.3343-3348.2004 ↗